Ladenburg Thalmann Financial Services’s Iovance Biotherapeutics IOVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | $205K | Buy |
7,402
+102
| +1% | +$2.83K | ﹤0.01% | 2476 |
|
|
2019
Q3 | $133K | Sell |
7,300
-400
| -5% | -$7.29K | ﹤0.01% | 2749 |
|
|
2019
Q2 | $189K | Buy |
7,700
+1,000
| +15% | +$24.5K | ﹤0.01% | 2514 |
|
|
2019
Q1 | $64K | Sell |
6,700
-468
| -7% | -$4.47K | ﹤0.01% | 3231 |
|
|
2018
Q4 | $63K | Sell |
7,168
-1,000
| -12% | -$8.79K | ﹤0.01% | 3097 |
|
|
2018
Q3 | $92K | Buy |
8,168
+2,468
| +43% | +$27.8K | ﹤0.01% | 2884 |
|
|
2018
Q2 | $96K | Hold |
5,700
| – | – | ﹤0.01% | 2780 |
|
|
2018
Q1 | $96K | Buy |
5,700
+3,275
| +135% | +$55.2K | ﹤0.01% | 2780 |
|
|
2017
Q4 | $20K | Buy |
2,425
+200
| +9% | +$1.65K | ﹤0.01% | 3803 |
|
|
2017
Q3 | $18K | Hold |
2,225
| – | – | ﹤0.01% | 3737 |
|
|
2017
Q2 | $17K | Sell |
2,225
-3,650
| -62% | -$27.9K | ﹤0.01% | 3701 |
|
|
2017
Q1 | $44K | Hold |
5,875
| – | – | ﹤0.01% | 3008 |
|
|
2016
Q4 | $41K | Hold |
5,875
| – | – | ﹤0.01% | 2983 |
|
|
2016
Q3 | $48K | Buy |
5,875
+4,650
| +380% | +$38K | ﹤0.01% | 2806 |
|
|
2016
Q2 | $10K | Hold |
1,225
| – | – | ﹤0.01% | 3774 |
|
|
2016
Q1 | $6K | Sell |
1,225
-500
| -29% | -$2.45K | ﹤0.01% | 3974 |
|
|
2015
Q4 | $14K | Buy |
1,725
+225
| +15% | +$1.83K | ﹤0.01% | 3471 |
|
|
2015
Q3 | $9K | Hold |
1,500
| – | – | ﹤0.01% | 3592 |
|
|
2015
Q2 | $14K | Hold |
1,500
| – | – | ﹤0.01% | 3461 |
|
|
2015
Q1 | $18K | Buy |
+1,500
| New | +$18K | ﹤0.01% | 3249 |
|